AKERO THERAPEUTICS INC (AKRO)
US00973Y1082 - Common Stock
ChartMill assigns a Buy % Consensus number of 81% to AKRO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 47.43. This target is 152.02% above the current price.
AKRO was analyzed by 16 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about AKRO.
In the previous month the buy percentage consensus was at a similar level.
AKRO was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-05-15 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-05-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-22 | B of A Securities | Reiterate | Neutral |
| 2024-03-05 | UBS | Maintains | Buy -> Buy |
| 2024-03-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-12 | UBS | Maintains | Buy -> Buy |
| 2023-10-11 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-10-11 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-10-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-10-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-04 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-09-19 | Cantor Fitzgerald | Initiate | Overweight |
| 2023-09-13 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2023-09-05 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-08-28 | UBS | Initiate | Buy |
| 2023-06-12 | Morgan Stanley | Maintains | Overweight |
| 2023-06-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-17 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2023-05-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-03-21 | Canaccord Genuity | Maintains | Buy |
| 2023-03-20 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-27 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2022-11-07 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-11-07 | HC Wainwright & Co. | Maintains | Buy |
| 2022-09-14 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
| 2022-09-14 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-11-15 | Morgan Stanley | Maintains | Equal-Weight |